Coastal Bridge Advisors, LLC Abbott Laboratories Transaction History

Coastal Bridge Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $6,844 - $8,029	72 Added 3.16%	2,353 $258,000
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $5,805 - $6,721	60 Added 2.7%	2,281 $221,000
Q2 2022 Nov 15, 2022	SELL	$102.07 - $123.37 $15,412 - $18,628	-151 Reduced 6.37%	2,221 $241,000
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $15,412 - $18,628	151 Added 6.8%	2,372 $258,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $68,297 - $83,284	599 Added 36.93%	2,221 $263,000
Q4 2021 May 20, 2022	SELL	$115.53 - $141.46 $72,552 - $88,836	-628 Reduced 27.91%	1,622 $228,000
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $262,485 - $290,385	2,250 New	2,250 $266,000

3,202

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $216B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.